![Wei Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Wei Yang is an Executive General Manager-Investment at Shanghai Fujian Equity Investment Fund Management Co., Ltd. He is on the Board of Directors at InxMed Ltd. Dr. Yang was previously employed as an Investment Director by Shenzhen Capital Group Co., Ltd. and a Vice President-Business Development by Simcere Pharmaceutical Group Ltd. He received his undergraduate degree from China Pharmaceutical University and a doctorate degree from Shanghai Institute of Materia Medica Chinese Academy of Sci.
Postes actifs de Wei Yang
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Wei Yang
| Sociétés | Poste | Fin |
|---|---|---|
Shenzhen Capital Group Co., Ltd.
 Shenzhen Capital Group Co., Ltd. Investment ManagersFinance SCGC is an active manager which invests in small and medium-sized, early-stage, seed-stage and expansion-stage Chinese companies in a range of sectors including hi-tech, service and logistics. The firm seeks to strengthen their cooperation with foreign venture capital firms in order to increase resource and value-added service capacity and to set up networks of stated-owned funds to improve the capability of project hunting and co-investment. SCGC seeks to exit investments through IPOs in Chinese and international exchanges, M&A, trade sales, share transfers and share repurchases. | Directeur en chef des Investissements | 01/04/2023 |
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Corporate Officer/Principal | 01/03/2021 |
Formation de Wei Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Simcere Pharmaceutical Group Ltd.
 Simcere Pharmaceutical Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes branded generic drugs | Health Technology |
Shenzhen Capital Group Co., Ltd.
Shenzhen Capital Group Co., Ltd. Investment ManagersFinance SCGC is an active manager which invests in small and medium-sized, early-stage, seed-stage and expansion-stage Chinese companies in a range of sectors including hi-tech, service and logistics. The firm seeks to strengthen their cooperation with foreign venture capital firms in order to increase resource and value-added service capacity and to set up networks of stated-owned funds to improve the capability of project hunting and co-investment. SCGC seeks to exit investments through IPOs in Chinese and international exchanges, M&A, trade sales, share transfers and share repurchases. | Finance |
China Pharmaceutical University
 China Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Institute of Materia Medica Chinese Academy of Sci
 Shanghai Institute of Materia Medica Chinese Academy of Sci Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
